Efficacy of phenylephrine [2]

British Journal of Clinical Pharmacology

Volumn 64, Issue 4, 2007, Pages 555-556

  Desjardins, Paul J ^a   Berlin, Roger G ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLEPHRINE; PSEUDOEPHEDRINE; DECONGESTIVE AGENT;

DRUG EFFECT; DRUG EFFICACY; FOOD AND DRUG ADMINISTRATION; LETTER; NOSE AIRWAY RESISTANCE; NOSE CONGESTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UNITED STATES; DRUG ABUSE; HUMAN; NOTE; TREATMENT OUTCOME;

AMPHETAMINE-RELATED DISORDERS; HUMANS; NASAL DECONGESTANTS; PHENYLEPHRINE; TREATMENT OUTCOME;

EID: 34548638538     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02935.x     Document Type: Letter

References (7)

1. Eccles R. Substitution of phenylephrine for pseudoephedrine as a nasal decongestant. An illogical way to control methamphetamine abuse. Br J Pharmacol 2006 63 : 10 14.
2. FDA. Establishment of a monograph for OTC cold. Cough, Allergy, Bronchodilator and Antiasthmatic Products. Federal Register 1976 38399 400.
3. Hendeles L, Hatton RC. Oral phenylephrine: an ineffective replacement for pseudoephedrine? J Allergy Clin Immunol 2006 118 : 279 80.
4. McLaurin JW, Shipman WF, Rosedal R Jr. Oral decongestants: a double blind comparison study of the effectiveness of four sympathomimetic drugs: objective and subjective. Laryngoscope 1961 71 : 54 67.
5. Cohen BM. Clinical and physiologic 'significance' in drug-induced changes in nasal flow/resistance. Eur J Clin Pharmacol 1972 5 : 81 6.
6. N). Presented at a Conference Sponsored by the Scientific Development Committee of the Proprietary Association, Washington DC, December 8, 1971.
7. Boyer DW. http://www.democrats.reform.house.gov/Documents/20060922172818- 85162.pdf. Accessed January 2, 2006.